Steven Bellon
Chief Scientific Officer Foghorn Therapeutics
Seminars
Wednesday 29th October 2025
Harnessing Degradation to Achieve Selectivity & First-in-Class Targeting of Challenging Chromatin Regulatory Proteins
3:45 pm
